Preview

Oncohematology

Advanced search
Fullscreen

For citations:


Vinogradova O.Yu., Pankraskina M.M., Neverova A.L., Shikhbabaeva D.I., Murzabekova M.A., Chernikov M.V., Popova A.V., Kosenkova V.P., Egoryan L.B., Ptushkin V.V. Clinical and hematological factors predicting the effectiveness of ruxolitinib in primary and secondary myelofibrosis. Results of a prospective single-center study. Oncohematology. 2024;19(3):16-33. (In Russ.) https://doi.org/10.17650/1818-8346-2024-19-3-16-33



Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1818-8346 (Print)
ISSN 2413-4023 (Online)